SEARCH Study

Jump to navigation Jump to search

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

SEARCH Study On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of SEARCH Study

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on SEARCH Study

CDC on SEARCH Study

SEARCH Study in the news

Blogs on SEARCH Study

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for SEARCH Study

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Objective

To study the efficacy and safety of prolonged use of more intensive cholesterol-lowering therapy in patients at high cardiovascular risk.

Methods

Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH) was a randomized, double blinded study which enrolled 12,064 men and women aged 18-80 years with a history of myocardial infarction. In addition these patients were randomly assigned to homocysteine lowering with folic acid 2 mg plus vitamin B12 1 mg daily versus matching placebo. The primary endpoint was major vascular events, defined as coronary death, myocardial infarction, stroke, or arterial revascularization.

Results

  • Major vascular events occurred in 24.5% of patients receiving 80 mg simvastatin versus 25.7% of those receiving 20 mg.
  • An average of 0.35 mmol/L greater reduction in LDL-C was observed in the group receiving 80 mg simvastatin compared to those receiving 20 mg.
  • Overall 6% reduction in major vascular events was observed in the 80 mg group compared with the 20 mg group.
  • Myopathy occurred in 0.9% patients taking 80 mg simvastatin compared with 0.03% patients in the 20 mg simvastatin group.

Conclusion

The SEARCH study failed to find a benefit with more intensive therapy as a significant number of patients in the 20 mg simvastatin group took an additional statin off protocol as more intensive LDL-C goals were promulgated.[1][2]

References

  1. Armitage J, Bowman L, Wallendszus K; et al. (2010). "Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial". Lancet. 376 (9753): 1658–69. doi:10.1016/S0140-6736(10)60310-8. PMC 2988223. PMID 21067805. Unknown parameter |month= ignored (help)
  2. Bowman L, Armitage J, Bulbulia R, Parish S, Collins R (2007). "Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors". American Heart Journal. 154 (5): 815–23, 823.e1–6. doi:10.1016/j.ahj.2007.06.034. PMID 17967584. Unknown parameter |month= ignored (help)